show episodes
 
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, the emergence of personalized medicine, aging in place, wearables and sensors, clinical trials and advances in clinical research, payer trends, transparency in the medical marketplace and challenges for connected health entrepreneurs. This show continues to evolve driven by the convergence of a diverse array of industries.
 
Stephen Hays is a recovering addict, living with type-1 bipolar disorder. He spent years living in addiction, and with untreated mental illness while he went from West Point graduate, to Wall Street Banker to nearly taking his own life when he hit bottom. On this show you will hear stories of addiction, mental illness, recovery, hope, and wellness. You will also hear from clinicians, experts, doctors, entrepreneurs and others who are trying to lead other people to wellness. We would love to ...
 
Conversational technology and patient engagement are two technology trends sweeping through the three trillion dollar healthcare industry. In these short, interactive discussions, industry experts talk about how and where innovation is impacting the customer experience at hospitals, pharmaceutical companies, and the vast array of related services in the industry.
 
Loading …
show series
 
Jessica Magana is the Product Manager of Lightbeam Health Solutions, a population health management company. Jessica shines a light on the biggest changes coming from CMS in risk adjustment for Medicare Advantage in 2022. Organizations need to understand the technical requirements behind the way diagnosed base risk scores will be calculated and the…
 
Jessica Magana is the Product Manager of Lightbeam Health Solutions, a population health management company. Jessica shines a light on the biggest changes coming from CMS in risk adjustment for Medicare Advantage in 2022. Organizations need to understand the technical requirements behind the way diagnosed base risk scores will be calculated and the…
 
Amanda Eilian, Founding Partner of _able Partners joins us to talk all things mental health startup investing. _able Partners is an early-stage VC firm supporting visionary founders in the positive living space. Their investments focus on companies that improve the daily lives of people, making them healthier, happier, and making their lives more m…
 
Dr. Hugh Rienhoff is the Founder and Chief Executive Officer at Imago BioSciences. He and his team are developing their lead asset bomedemstat for the treatment of myeloproliferative neoplasms (MPNs) which are rare blood cancers. Hugh explains, "So MPNs, myeloproliferative neoplasms, are actually a family of diseases that include myelofibrosis, pol…
 
Dr. Hugh Rienhoff is the Founder and Chief Executive Officer at Imago BioSciences. He and his team are developing their lead asset bomedemstat for the treatment of myeloproliferative neoplasms (MPNs) which are rare blood cancers. Hugh explains, "So MPNs, myeloproliferative neoplasms, are actually a family of diseases that include myelofibrosis, pol…
 
Eric Rock is the Founder and CEO of Vivify Health and a pioneer in the application of remote patient monitoring, consumer electronics, and biometric devices combined with virtual visits to connect patients and providers outside the hospital setting. Eric explains, "Fortunately, Vivify, from our beginning days, created a solution that encompassed a …
 
Eric Rock is the Founder and CEO of Vivify Health and a pioneer in the application of remote patient monitoring, consumer electronics, and biometric devices combined with virtual visits to connect patients and providers outside the hospital setting. Eric explains, "Fortunately, Vivify, from our beginning days, created a solution that encompassed a …
 
Craig Parker is the Chief Executive Officer at Surrozen. Their research in the Wnt pathway and proteins identified these are critical to maintaining tissues in our body and are found in tissues as diverse as the lung, intestine, liver, sensory hair cells, and the eye. The company is first targeting a patient population with a severe alcoholic injur…
 
Craig Parker is the Chief Executive Officer at Surrozen. Their research in the Wnt pathway and proteins identified these are critical to maintaining tissues in our body and are found in tissues as diverse as the lung, intestine, liver, sensory hair cells, and the eye. The company is first targeting a patient population with a severe alcoholic injur…
 
Dr. Richard Watson is a Co-Founder of Motient and has taken on the challenge of creating an efficient solution to solve the puzzle of how to move patients from one place to another with a focus on rural healthcare and rural hospitals. Motient was founded as a medical transport company that did air and ground transport. They have now created Mission…
 
Dr. Richard Watson is a Co-Founder of Motient and has taken on the challenge of creating an efficient solution to solve the puzzle of how to move patients from one place to another with a focus on rural healthcare and rural hospitals. Motient was founded as a medical transport company that did air and ground transport. They have now created Mission…
 
The healthcare system always operated in a way that depended on providers to do the right thing, to step up and make sure nobody gets left behind. With the COVID-19 pandemic raging through a second year, the strains being placed on doctors, nurses, and other caregivers has been intense. In many ways, the pandemic has exposed the flaws of a system t…
 
David Katz is the Chief Scientific Officer at Sparrow Pharmaceuticals. He is exploring the possibility of blocking the formation of intracellular steroids to reduce the side effects of steroid medicines and conditions related to the overproduction of cortisol in the body in such diseases as Cushing's Syndrome and autonomous cortisol secretion. Davi…
 
David Katz is the Chief Scientific Officer at Sparrow Pharmaceuticals. He is exploring the possibility of blocking the formation of intracellular steroids to reduce the side effects of steroid medicines and conditions related to the overproduction of cortisol in the body in such diseases as Cushing's Syndrome and autonomous cortisol secretion. Davi…
 
Hideki Garren MD Ph.D. is the Chief Medical Officer at Prothena with a mission to advance the pipeline of candidates for neurodegenerative and protein amyloid diseases, including Alzheimer's and Parkinson's. We talk about the recent FDA approval of aducanumab and its impact on research. Hideki says, "As we've shown at the AAIC, the Alzheimer's Asso…
 
Hideki Garren MD Ph.D. is the Chief Medical Officer at Prothena with a mission to advance the pipeline of candidates for neurodegenerative and protein amyloid diseases, including Alzheimer's and Parkinson's. We talk about the recent FDA approval of aducanumab and its impact on research. Hideki says, "As we've shown at the AAIC, the Alzheimer's Asso…
 
Karen Chen is the Chief Executive Officer of the Spinal Muscular Atrophy Foundation. With a background in drug development having worked in pharma and biotech in neurodegenerative diseases like Alzheimer's and Parkinson's, Karen brings a deep understanding of the value of treating rare diseases that are genetically defined. Karen explains, "The fou…
 
Karen Chen is the Chief Executive Officer of the Spinal Muscular Atrophy Foundation. With a background in drug development having worked in pharma and biotech in neurodegenerative diseases like Alzheimer's and Parkinson's, Karen brings a deep understanding of the value of treating rare diseases that are genetically defined. Karen explains, "The fou…
 
Today’s guest is John Donoghue. He is well known for his groundbreaking work developing Brain Computer Interfaces (BCIs) to restore movement for people with paralysis, known as ‘BrainGate’. BrainGate was the original BCI system created by a company called Cyberkinetics, of which John was a co-founder. In this episode, John gives us a primer on BCIs…
 
Sanjay Shukla is the President and CEO of aTyr Pharma, focusing on the extracellular functionality and signaling pathways of tRNA synthetases. The lead clinical product candidate ATYR1923 is a potential disease-modifying therapy for patients with severe inflammatory lung diseases, including interstitial lung disease pulmonary sarcoidosis. Sanjay ex…
 
Sanjay Shukla is the President and CEO of aTyr Pharma, focusing on the extracellular functionality and signaling pathways of tRNA synthetases. The lead clinical product candidate ATYR1923 is a potential disease-modifying therapy for patients with severe inflammatory lung diseases, including interstitial lung disease pulmonary sarcoidosis. Sanjay ex…
 
Dr. Elizabeth Marshall is the Director of Clinical Analytics at Linguamatics an IQVIA company, where she is responsible for clinical oversight of all healthcare projects with a focus on the application of Natural Language Processing in drug development and healthcare. NLP is a type of artificial intelligence that is concerned with the interaction b…
 
Dr. Elizabeth Marshall is the Director of Clinical Analytics at Linguamatics an IQVIA company, where she is responsible for clinical oversight of all healthcare projects with a focus on the application of Natural Language Processing in drug development and healthcare. NLP is a type of artificial intelligence that is concerned with the interaction b…
 
Dan Temple is a patient advocate for those with Spinal Muscular Atrophy (SMA) and he shares his treatment journey and actions he has taken to raise awareness about SMA. We also talk about the drug treatments that have come onto the scene since he was first diagnosed when Dan was 2 years old. He is now 49. Dan says, "Like I said, very important was …
 
Dan Temple is a patient advocate for those with Spinal Muscular Atrophy (SMA) and he shares his treatment journey and actions he has taken to raise awareness about SMA. We also talk about the drug treatments that have come onto the scene since he was first diagnosed when Dan was 2 years old. He is now 49. Dan says, "Like I said, very important was …
 
Professor Florian Solzbacher is the Co-Founder and Chairman of Blackrock Neurotech and is focused on expanding the options, understanding, and marketing of brain computer interfaces and neuro devices. I asked Florian about their new project underway with Northwestern University and DARPA called the NTRAIN Project. He said, "The key driving force be…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login